A vaccine for the world’s most common cause of acute gastroenteritis and the USA’s most common cause of foodborne illness is now in human clinical trials. The trial by Japan’s Takeda Pharmaceutical Co. Ltd. involves
Continue Reading Takeda’s norovirus vaccine first to reach human trials
Worldwide human and economic costs of norovirus are huge
Leave it to the federal Centers for Disease Control and Prevention to put a price tag on the worldwide cost of norovirus. After a CDC-sponsored symposium in February, scientists and experts calculated the global numbers,
Continue Reading Worldwide human and economic costs of norovirus are huge